Grand Hyatt Hotel,
Athens, 2 – 5/09/2021
IASIS PHARMA participated with physical presence in the 4th hybrid Panhellenic Congress under the title: “Dermatological diseases 2021: Past, present and future” which was held on September 2-5 at Grand Hyatt Hotel Athens.
At IASIS PHARMA exhibition stand, two of its major Dermatological products were presented:
Modiwart® / Imiquimod: modifier of the immune response system (innovative immunomodulator), indicated for the treatment of:
a) External genital warts,
b) Superficial basal cell carcinoma (sBCC) and
c) Actinic keratosis (AK).
Isotroin® / Isotretinoin: a retinoid for the treatment of severe acne in oral form (soft caps) with the unique strength of 40mg in the Greek market but also in soft caps of 20mg & 10mg.
